Navigation Links
Laurence Debroux Appointed Chief Strategic Officer (CSO)

PARIS, Feb. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that Laurence Debroux is appointed Senior Vice-President, Chief Strategic Officer (CSO).

In light of the implementation of the Group's development strategy, it has been decided to create the position of Chief Strategic Officer at the Executive Committee level.

This position will cover all Group's business development and acquisition activities as well as corporate planning, financial and economic evaluation of internal and external projects, and strategic intelligence.

The CSO will ensure that development projects are coherent with corporate strategy and fulfill rigorous requirements for shareholder value creation.

Laurence Debroux is appointed to this position and will report to Chris Viehbacher, Chief Executive Officer of sanofi-aventis.

Laurence was previously Senior Vice President, Chief Financial Officer. She will keep this position and ensure an orderly transition pending the imminent appointment of a new CFO.

Laurence Debroux is a graduate of HEC (Ecole des Hautes Etudes Commerciales). She began her career with Merrill Lynch in London, and then worked in the Finance Department of the Elf Aquitaine Group from 1993 to 1996. She joined the Sanofi Group as Corporate Treasurer in 1996, and was appointed Head of Financing/Treasury in 1997. From 2000 to 2004, she served as Head of Strategic Planning, before becoming Deputy Chief Financial Officer. As from March 2007 she was appointed Senior Vice President, Chief Financial Officer and became a member of the Executive Committee in December 2008.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

    CONTACT:  Jean-Marc Podvin
              Vice President, Media Relations

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
2. William Moore Appointed to IRIDEX Board of Directors
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
5. James B. Hawkins Appointed to IRIDEX Board of Directors
6. Bryan R. Rogers Appointed President of Far West Division
7. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
8. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
9. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
10. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
11. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
Post Your Comments:
(Date:10/12/2015)... ... October 13, 2015 , ... Career Step, an online ... of its new Professional Medical Coding and Billing with Applied PCS career training ... ICD-10-PCS code sets, earn the Certified Professional Coder (CPC) and Certified Coding Associate ...
(Date:10/12/2015)... , ... October 12, 2015 , ... ... August 19, 2015, high school aged female athletes, particularly in the area of ... repetitive motion and mechanical overuse injuries than male peers in the same age ...
(Date:10/12/2015)... Los Angeles, CA (PRWEB) , ... October 12, 2015 , ... ... 7th, the Fire Chief for the city of San Antonio, Texas recommended that any ... retrofitted to incorporate these important safety systems going forward. The article explains that it ...
(Date:10/12/2015)... ... October 12, 2015 , ... AcousticSheep LLC, ... Cleveland Clinic in honor of Breast Cancer Awareness Month. During the month ... will donate a SleepPhones® Classic product to a breast cancer patient at the ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... On July ... MN. Their mission: To paddle the entire 2,320-miles of river to the Gulf of ... halfway done with the monumental journey, with two months remaining for a November 22nd ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... October 12, 2015 ... to grow at 7.2% CAGR, microscopy market ... rising focus on nanotechnology, technological advancements, and ... report available with ... . --> Complete report on ...
(Date:10/12/2015)...   Royal Philips (NYSE: PHG, AEX: PHIA), ... a collaboration with Genomic Health , Inc. (NASDAQ: ... diagnostic tests, to leverage Philips digital pathology tools in ... testing processes.    --> ... samples and plays a crucial role in the diagnosis ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: ... District of Delaware granted the Company,s ... Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to market ... (buprenorphine and naloxone) Sublingual Film (CIII) in the ... --> Since August 2013, Indivior has received Paragraph IV ...
Breaking Medicine Technology: